First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2026 revenue reaching $5.8B — +15.5% growth in a single year.
Why Revenue Could Accelerate
1Same-store occupancy trends across the portfolio (currently estimated 82-85% vs pre-pandemic 87-89%), as 100bps occupancy improvement translates to $15-20M annual EBITDA
2Acquisition pipeline execution and integration success rates—company targets $150-250M annual acquisition spend at 5-6x EBITDA with 18-24 month payback periods
3Medicare reimbursement rate updates (annual market basket increases typically 2-3%) and state Medicaid rate adequacy, particularly in California and Texas which represent 40%+ of facilities
4Labor cost inflation and staffing availability, as nursing wages represent 55-60% of operating costs and CNA shortages can limit census growth
5Regulatory developments including CMS staffing mandates, quality star ratings impact on referrals, and state certificate-of-need restrictions on new facility development
growth - The stock attracts growth-at-reasonable-price (GARP) investors seeking exposure to demographic tailwinds (aging population)…
Rising rates create moderate headwinds through two channels: (1) Higher acquisition financing costs—ENSG uses variable-rate credit…
Watch on earnings: CMS Medicare Advantage penetration rate (currently ~50% of Medicare beneficiaries)—higher MA penetration shifts reimbursement from fee-for-service to managed care contracts with 5-10% lower rates, Bureau of Labor Statistics healthcare wage inflation (RN and CNA hourly wages)—nursing labor represents 55-60% of costs, so wage growth exceeding reimbursement rate increases compresses margins, State Medicaid budget allocations for long-term care in California, Texas, Arizona—these three states represent 50%+ of ENSG facilities and Medicaid rate adequacy varies significantly by state fiscal health.
One Sentence Summary:
The bull case is simple: analysts see revenue climbing from $5.8B to $6.4B as same-store occupancy trends across the portfolio (currently estimated 82-85% vs pre-pandemic 87-89%).
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.